project id: TCGA-BRCA; case submitter id: TCGA-LD-A7W6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.81; rna integrity number: 9.4; age at index: 54; days to birth: -20077; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 20077; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 404.0; icd 10 code: C50.2; last known disease status: not reported; morphology: 8524/3; primary diagnosis: Infiltrating lobular mixed with other types of carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper-inner quadrant of breast; synchronous malignancy: No; tissue or organ of origin: Upper-inner quadrant of breast; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 91; days to sample procurement: 0; initial weight: 630.0; portion submitter id: TCGA-LD-A7W6-01A-81; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0;